Global Clinical Mass Spectrometry Market, by Product Type (Gas chromatography–mass spectrometry (GC-MS) instrument, Liquid chromatography–mass spectrometry (LC-MS) instrument, MALDI-TOF mass spectrometer, Capillary electrophoresis–mass spectrometry, and Ion mobility spectrometry-mass spectrometry), by Application (Clinical Testing, Proteomics, and Drug discovery), by End User (Research Laboratories, Diagnostic Laboratories, and Hospitals), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) is estimated to be valued at US$ 697.2 million in 2019, and is expected to exhibit a CAGR of 5.5% over the forecast period (2019 - 2027). Increasing investments in R&D activities by pharmaceutical companies are driving growth of the global clinical mass spectrometry market. Mass spectrometry continues to play a prominent role in laboratory medicine. For instance, in 2019, Biotage AB collaborated with Shandong Yingsheng Biotechnology Co., Ltd to focus on research, production and selling in vitro diagnostic reagents and medical equipment, building a genetic detection platform and mass spectrometry detection platform around metabolomics and genetics.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/193

As a part of the collaboration, Biotage and Yingsheng agreed to develop clinical mass spectrometry applications in China, where Biotage will provide systems and consumables through its analytical chemistry portfolio and Yingsheng will sell it with its brand name. Moreover, use of clinical mass spectrometry in laboratory developed tests (LDTs) is driving growth of this market. Properties such as sensitive analytical capabilities and enhancements continue to bring the technology to the edge of new scientific discovery and research applications. Matrix-assisted laser desorption/ionization - time of flight (MALDI-TOF) have wide application in microbiology laboratories. MALDI-TOF systems that have been designated as medical devices that support FDA-cleared or CE-marked assays. Assays that have received FDA clearance or CE-marking over the last few years have largely revolved around microbiological identifications with MALDI-TOF. These assays are different from the majority of the clinical mass spectrometry market, which is covered by laboratory developed tests (LDTs).

Browse 43 Market Data Tables and 33 Figures spread through 169 Pages and in-depth TOC on "Global Clinical Mass Spectrometry Market, by Product Type (Gas chromatography–mass spectrometry (GC-MS) instrument , Liquid chromatography–mass spectrometry (LC- MS) instrument, MALDI-TOF mass spectrometer, Capillary electrophoresis–mass spectrometry, and Ion mobility spectrometry-mass spectrometry), by Application (Clinical Testing, Proteomics, and Drug discovery), by End User (Research Laboratories, Diagnostic Laboratories, and Hospitals), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Global Forecast to 2027"

Browse Research Report: https://www.coherentmarketinsights.com/market-insight/clinical-mass-spectrometry-market-193

Key Takeaways of the Clinical Mass Spectrometry Market:

The global clinical mass spectrometry market is expected to exhibit a CAGR of 5.5% over the forecast period (2019 – 2027), owing to technological advancements in mass spectrometry and increasing adoption in laboratory developed tests.

Among region, Asia Pacific is expected to witness significant growth in the global clinical mass spectrometry market over the forecast period, owing to high R&D investment by pharmaceutical companies.

Gas chromatography – mass spectrometry (GC-MS) instrument segment held a dominant position in clinical mass spectrometry market, owing to high adoption of this technology by players operating in the market.

Major players operating in the global clinical mass spectrometry market include Bruker Corporation, Kore Technology Limited, Bergman Messgerate Entwicklung KG, Mass Spectrometry Instruments (MSI), Thermo Fisher Scientific Inc., Agilent Technologies, and Danaher Corporations.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/193

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
mailto:[email protected]
U.S. Office:
Name: Mr. Shah
Coherent Market Insights 1001 4th Ave,
# 3200 Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737